Pfizer Asia Pacific Pte LtdIn order to further develop Lava IP International’s business development capabilities in the Pharmaceutical Engineering sector, we were pleased to participate in the recent ISPE seminar and workshop on trends in the Flexible Containment of Filtration Applications.

Presented by Dr. Gareth Leach from Pall Life Sciences, this informative seminar gave us a deep insight into several important trends in the technologies used by leading pharmaceutical manufacturers.

Hosted at Pfizer Asia Pacific Pte Ltd (PAPPL)’s $640 million Singapore dollar active pharmaceutical ingredient (API) manufacturing facility in Tuas Biomedical Park, this was an opportunity for Lava IP International to visit Pfizer’s first large scale API manufacturing facility in Asia. Other companies now present in Tuas Biomedical Park include MSD, Wyeth, Ciba Vision, GSK Biologicals, Novartis, Lonza Biologics and Abbott Nutritionals.

The seminar was attended by about 20 representatives from Pfizer, ISPE, Pall Life Sciences, Foster Wheeler, Dunreidy Engineering, and Lava IP International, and we would like to thank everyone at ISPE for this opportunity to learn more on behalf of companies which use our business development services in the pharmaceutical engineering sector.